Skip to main content
Becton, Dickinson and Company (BDX)
NYSE: BDX · Real-Time Price · USD
169.94
-1.55 (-0.90%)
Mar 5, 2026, 4:00 PM EST - Market closed

BDX Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Medical
11.46B 11.14B 10.77B 10.46B 10.07B 9.79B 9.67B 9.58B
Medical Growth
13.73% 13.77% 11.41% 9.20% 6.02% 11.45% 13.17% 11.40%
Interventional
5.22B 5.11B 5.02B 5.05B 4.98B 4.92B 4.90B 4.80B
Interventional Growth
4.74% 3.78% 2.45% 5.30% 5.15% 6.35% 7.64% 7.08%
Life Sciences
5.17B 5.14B 5.14B 5.20B 5.19B 5.18B 5.15B 5.12B
Life Sciences Growth
-0.48% -0.87% -0.10% 1.58% 1.13% 1.81% -0.48% -4.90%

Revenue by Geography
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
United States
12.79B 12.49B 12.20B 11.99B 11.66B 11.43B 11.31B 11.13B
United States Growth
9.67% 9.28% 7.88% 7.74% 4.95% 7.24% 7.41% 5.03%
International
9.05B 8.90B 8.67B 8.65B 8.52B 8.40B 8.41B 8.36B
International Growth
6.27% 5.93% 3.12% 3.45% 3.11% 7.00% 8.59% 6.34%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.